Gene expression profile at week 2 of neoadjuvant therapy course predicts outcome in HER2-positive breast cancer patients: an explorative analysis from NeoALTTO. (November 2022) - Di Cosimo, S.; Pizzamiglio, S.; Sotiriou, C.; Ciniselli, C.M.; Triulzi, T.; de Cecco, L.; El-Abed, S.; Izquierdo, M.; de Azambuja, E.; Saura, C.; Huober, J.; Untch, M.; et al.